BEVERLY, Mass. — It was fitting, one activist said, that the sky was storming on the night before the North Shore Birth Center closed, as patients, midwives
Tag - Boston
“Can you give me a thumbs up?” the surgeon asks Jerry Majetich, an Iraq War veteran, during a checkup this spring at a Boston hospital. “Can you make me a fist
Biogen CEO Michel Vounatsos admitted Thursday that the launch of Aduhelm, the company’s intensely scrutinized treatment for Alzheimer’s disease, has been
Dyno Therapeutics, a Cambridge biotech that uses artificial intelligence techniques to develop gene therapies, said Thursday that it has raised $100 million
Thermo Fisher Scientific announced Thursday that it will buy PPD, a contract-research company for the pharmaceutical and biotech industries, in a deal valued
Just over two months after announcing its debut with $108 million in funding, Boston startup Scorpion Therapeutics said Thursday it has raised an even larger
A new biotechnology company was launched Thursday in Cambridge with $81 million in funding, joining a growing number of biotechs in the area that are based on
A top researcher at the Massachusetts Institute of Technology on Thursday said that artificial intelligence systems developed for medicine must be more
Disarm Therapeutics, a Cambridge biotechnology firm working on new potential drugs for neurological diseases such as ALS and multiple sclerosis, will be bought
Casma Therapeutics, a Cambridge biotech trying to develop new medicines based on discoveries about how cells detoxify and repair themselves, has raised $50
